Automated description from the Alliance of Genome Resources (Release 7.1.0)
Predicted to enable caffeine oxidase activity; heme binding activity; and monooxygenase activity. Predicted to be involved in epoxygenase P450 pathway and xenobiotic metabolic process. Predicted to be located in plasma membrane. Predicted to be active in cytoplasm and intracellular membrane-bounded organelle. Human ortholog(s) of this gene implicated in several diseases, including end stage renal disease; glucose metabolism disease (multiple); head and neck squamous cell carcinoma; hypertension (multiple); and warfarin resistance. Orthologous to human CYP2C8 (cytochrome P450 family 2 subfamily C member 8) and CYP2C9 (cytochrome P450 family 2 subfamily C member 9).